Skip to main content
Erschienen in: Digestive Diseases and Sciences 11/2018

09.08.2018 | Original Article

Influence of Obesity and Metabolic Abnormalities on the Risk of Developing Colorectal Neoplasia

verfasst von: Nam Hee Kim, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Chong Il Sohn

Erschienen in: Digestive Diseases and Sciences | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Obesity and metabolic syndrome are risk factors for colorectal neoplasia (CRN). However, the association between metabolically healthy obese (MHO) or metabolically unhealthy non-obese (MUNO) status and the risk of CRN remains unclear.

Aims

We aimed to elucidate the association between MHO or MUNO status and the risk of CRN.

Methods

A total of 139,023 asymptomatic subjects who underwent a primary screening colonoscopy were categorized into 4 groups according to obesity and metabolic status: metabolically healthy non-obese (MHNO), MHO, MUNO, and metabolically unhealthy obese (MUO).

Results

Mean participant age was 41.0 years, and the proportion of men was 65.3%. Among men, the risk of overall CRN increased in MHO (adjusted odds ratio [AOR] 1.22, 95% confidence intervals [CI] 1.12–1.33), MUNO (AOR 1.25, 95% CI 1.18–1.31), and MUO groups (AOR 1.47, 95% CI 1.40–1.54) compared with the MHNO group, whereas the risk of advanced CRN (ACRN) increased in MUNO (AOR 1.16, 95% CI 1.002–1.33) and MUO groups (AOR 1.49, 95% CI 1.31–1.70), but not in the MHO group (AOR 0.92, 95% CI 0.70–1.21). Moreover, among non-obese men, the risk of overall CRN and ACRN linearly increased with an increasing number of metabolic abnormalities. However, among women, only the MUO group had an increased risk of overall CRN (AOR 1.34, 95% CI 1.21–1.47) and no other significant associations were observed.

Conclusions

Poor metabolic health, regardless of obesity, is an independent risk factor for CRN in men. Our results suggest that men with metabolic abnormalities should be considered as a high-risk group for colorectal cancer, even if they are not obese.
Literatur
1.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.CrossRef Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.CrossRef
2.
Zurück zum Zitat Ng SC, Wong SH. Colorectal cancer screening in Asia. Br Med Bull. 2013;105:29–42.CrossRef Ng SC, Wong SH. Colorectal cancer screening in Asia. Br Med Bull. 2013;105:29–42.CrossRef
3.
Zurück zum Zitat Ma Y, Yang Y, Wang F, et al. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS ONE. 2013;8:e53916.CrossRef Ma Y, Yang Y, Wang F, et al. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS ONE. 2013;8:e53916.CrossRef
4.
Zurück zum Zitat Okabayashi K, Ashrafian H, Hasegawa H, et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol. 2012;107:1175–1185.CrossRef Okabayashi K, Ashrafian H, Hasegawa H, et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol. 2012;107:1175–1185.CrossRef
5.
Zurück zum Zitat Suchanek S, Grega T, Ngo O, et al. How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia? World J Gastroenterol. 2016;22:8103–8111.CrossRef Suchanek S, Grega T, Ngo O, et al. How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia? World J Gastroenterol. 2016;22:8103–8111.CrossRef
6.
Zurück zum Zitat Jinjuvadia R, Lohia P, Jinjuvadia C, Montoya S, Liangpunsakul S. The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis. J Clin Gastroenterol. 2013;47:33–44.CrossRef Jinjuvadia R, Lohia P, Jinjuvadia C, Montoya S, Liangpunsakul S. The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis. J Clin Gastroenterol. 2013;47:33–44.CrossRef
7.
Zurück zum Zitat Kopp W. High-insulinogenic nutrition–an etiologic factor for obesity and the metabolic syndrome? Metabolism. 2003;52:840–844.CrossRef Kopp W. High-insulinogenic nutrition–an etiologic factor for obesity and the metabolic syndrome? Metabolism. 2003;52:840–844.CrossRef
8.
Zurück zum Zitat Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168:1609–1616.CrossRef Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168:1609–1616.CrossRef
9.
Zurück zum Zitat Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond). 2011;35:971–981.CrossRef Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond). 2011;35:971–981.CrossRef
10.
Zurück zum Zitat Sims EA. Are there persons who are obese, but metabolically healthy? Metabolism. 2001;50:1499–1504.CrossRef Sims EA. Are there persons who are obese, but metabolically healthy? Metabolism. 2001;50:1499–1504.CrossRef
11.
Zurück zum Zitat Brochu M, Tchernof A, Dionne IJ, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab. 2001;86:1020–1025.PubMed Brochu M, Tchernof A, Dionne IJ, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab. 2001;86:1020–1025.PubMed
12.
Zurück zum Zitat Fruhbeck G, Toplak H, Woodward E, Halford JC, Yumuk V. Need for a paradigm shift in adult overweight and obesity management: an EASO position statement on a pressing public health, clinical and scientific challenge in Europe. Obes Facts. 2014;7:408–416.CrossRef Fruhbeck G, Toplak H, Woodward E, Halford JC, Yumuk V. Need for a paradigm shift in adult overweight and obesity management: an EASO position statement on a pressing public health, clinical and scientific challenge in Europe. Obes Facts. 2014;7:408–416.CrossRef
13.
Zurück zum Zitat Puri R. Is it finally time to dispel the concept of metabolically-healthy obesity? J Am Coll Cardiol. 2014;63:2687–2688.CrossRef Puri R. Is it finally time to dispel the concept of metabolically-healthy obesity? J Am Coll Cardiol. 2014;63:2687–2688.CrossRef
14.
Zurück zum Zitat Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med. 2013;159:758–769.CrossRef Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med. 2013;159:758–769.CrossRef
15.
Zurück zum Zitat Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med. 2008;168:1617–1624.CrossRef Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med. 2008;168:1617–1624.CrossRef
16.
Zurück zum Zitat Murphy N, Cross AJ, Abubakar M, et al. A nested case-control study of metabolically defined body size phenotypes and risk of colorectal cancer in the european prospective investigation into cancer and nutrition (EPIC). PLoS Med. 2016;13:e1001988.CrossRef Murphy N, Cross AJ, Abubakar M, et al. A nested case-control study of metabolically defined body size phenotypes and risk of colorectal cancer in the european prospective investigation into cancer and nutrition (EPIC). PLoS Med. 2016;13:e1001988.CrossRef
17.
Zurück zum Zitat Kim MC, Kim CS, Chung TH, et al. MONW phenotype is associated with advanced colorectal adenoma in Korean men. Obesity (Silver Spring). 2012;20:1876–1881.CrossRef Kim MC, Kim CS, Chung TH, et al. MONW phenotype is associated with advanced colorectal adenoma in Korean men. Obesity (Silver Spring). 2012;20:1876–1881.CrossRef
18.
Zurück zum Zitat Ko SH, Baeg MK, Ko SY, Jung HS, Kim P, Choi MG. Obesity and metabolic unhealthiness have different effects on colorectal neoplasms. J Clin Endocrinol Metab. 2017;102:2762–2769.CrossRef Ko SH, Baeg MK, Ko SY, Jung HS, Kim P, Choi MG. Obesity and metabolic unhealthiness have different effects on colorectal neoplasms. J Clin Endocrinol Metab. 2017;102:2762–2769.CrossRef
19.
Zurück zum Zitat Sinn DH, Min YW, Son HJ, et al. Metabolically-healthy obesity is associated with higher prevalence of colorectal adenoma. PLoS ONE. 2017;12:e0179480.CrossRef Sinn DH, Min YW, Son HJ, et al. Metabolically-healthy obesity is associated with higher prevalence of colorectal adenoma. PLoS ONE. 2017;12:e0179480.CrossRef
20.
Zurück zum Zitat Shin CM, Han K, Lee DH, et al. Association among obesity, metabolic health, and the risk for colorectal cancer in the general population in Korea using the national health insurance service-national sample cohort. Dis Colon Rectum. 2017;60:1192–1200.CrossRef Shin CM, Han K, Lee DH, et al. Association among obesity, metabolic health, and the risk for colorectal cancer in the general population in Korea using the national health insurance service-national sample cohort. Dis Colon Rectum. 2017;60:1192–1200.CrossRef
21.
Zurück zum Zitat Kim JY, Park DI, Yu J, et al. Increased risk of advanced colorectal neoplasia among korean men with metabolic abnormality and obesity. Clin Gastroenterol Hepatol. 2016;14:1310.e1312–1316.e1312. Kim JY, Park DI, Yu J, et al. Increased risk of advanced colorectal neoplasia among korean men with metabolic abnormality and obesity. Clin Gastroenterol Hepatol. 2016;14:1310.e1312–1316.e1312.
22.
Zurück zum Zitat Soweid AM, Kobeissy AA, Jamali FR, et al. A randomized single-blind trial of standard diet versus fiber-free diet with polyethylene glycol electrolyte solution for colonoscopy preparation. Endoscopy. 2010;42:633–638.CrossRef Soweid AM, Kobeissy AA, Jamali FR, et al. A randomized single-blind trial of standard diet versus fiber-free diet with polyethylene glycol electrolyte solution for colonoscopy preparation. Endoscopy. 2010;42:633–638.CrossRef
23.
Zurück zum Zitat Wen CP, David Cheng TY, Tsai SP, et al. Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutr. 2009;12:497–506.CrossRef Wen CP, David Cheng TY, Tsai SP, et al. Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutr. 2009;12:497–506.CrossRef
24.
Zurück zum Zitat Lee SY, Park HS, Kim DJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract. 2007;75:72–80.CrossRef Lee SY, Park HS, Kim DJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract. 2007;75:72–80.CrossRef
25.
Zurück zum Zitat Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645.CrossRef Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645.CrossRef
26.
Zurück zum Zitat Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143:844–857.CrossRef Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143:844–857.CrossRef
27.
Zurück zum Zitat Leslie A, Carey FA, Pratt NR, Steele RJ. The colorectal adenoma-carcinoma sequence. Br J Surg. 2002;89:845–860.CrossRef Leslie A, Carey FA, Pratt NR, Steele RJ. The colorectal adenoma-carcinoma sequence. Br J Surg. 2002;89:845–860.CrossRef
28.
Zurück zum Zitat Pfalzer AC, Kamanu FK, Parnell LD, et al. Interactions between the colonic transcriptome, metabolome, and microbiome in mouse models of obesity-induced intestinal cancer. Physiol Genomics. 2016;48:545–553.CrossRef Pfalzer AC, Kamanu FK, Parnell LD, et al. Interactions between the colonic transcriptome, metabolome, and microbiome in mouse models of obesity-induced intestinal cancer. Physiol Genomics. 2016;48:545–553.CrossRef
29.
Zurück zum Zitat Yaoita T, Sasaki Y, Yokozawa J, et al. Treatment with anti-interleukin-6 receptor antibody ameliorates intestinal polyposis in Apc(Min/+) mice under high-fat diet conditions. Tohoku J Exp Med. 2015;235:127–134.CrossRef Yaoita T, Sasaki Y, Yokozawa J, et al. Treatment with anti-interleukin-6 receptor antibody ameliorates intestinal polyposis in Apc(Min/+) mice under high-fat diet conditions. Tohoku J Exp Med. 2015;235:127–134.CrossRef
30.
Zurück zum Zitat Aleksandrova K, Nimptsch K, Pischon T. Influence of obesity and related metabolic alterations on colorectal cancer risk. Curr Nutr Rep. 2013;2:1–9.CrossRef Aleksandrova K, Nimptsch K, Pischon T. Influence of obesity and related metabolic alterations on colorectal cancer risk. Curr Nutr Rep. 2013;2:1–9.CrossRef
31.
Zurück zum Zitat Hu YP, Patil SB, Panasiewicz M, et al. Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor. Cancer Res. 2008;68:8004–8013.CrossRef Hu YP, Patil SB, Panasiewicz M, et al. Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor. Cancer Res. 2008;68:8004–8013.CrossRef
32.
Zurück zum Zitat Markman B, Javier Ramos F, Capdevila J, Tabernero J. EGFR and KRAS in colorectal cancer. Adv Clin Chem. 2010;51:71–119.CrossRef Markman B, Javier Ramos F, Capdevila J, Tabernero J. EGFR and KRAS in colorectal cancer. Adv Clin Chem. 2010;51:71–119.CrossRef
33.
Zurück zum Zitat Edvardsson K, Strom A, Jonsson P, Gustafsson JA, Williams C. Estrogen receptor beta induces antiinflammatory and antitumorigenic networks in colon cancer cells. Mol Endocrinol. 2011;25:969–979.CrossRef Edvardsson K, Strom A, Jonsson P, Gustafsson JA, Williams C. Estrogen receptor beta induces antiinflammatory and antitumorigenic networks in colon cancer cells. Mol Endocrinol. 2011;25:969–979.CrossRef
34.
Zurück zum Zitat Yamaji T, Iwasaki M, Sasazuki S, Tsugane S. Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia. Int J Obes (Lond). 2012;36:440–447.CrossRef Yamaji T, Iwasaki M, Sasazuki S, Tsugane S. Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia. Int J Obes (Lond). 2012;36:440–447.CrossRef
35.
Zurück zum Zitat Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the u.s. multi-society task force on colorectal cancer. Am J Gastroenterol. 2017;112:1016–1030.CrossRef Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the u.s. multi-society task force on colorectal cancer. Am J Gastroenterol. 2017;112:1016–1030.CrossRef
Metadaten
Titel
Influence of Obesity and Metabolic Abnormalities on the Risk of Developing Colorectal Neoplasia
verfasst von
Nam Hee Kim
Yoon Suk Jung
Jung Ho Park
Dong Il Park
Chong Il Sohn
Publikationsdatum
09.08.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 11/2018
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5239-5

Weitere Artikel der Ausgabe 11/2018

Digestive Diseases and Sciences 11/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.